Target intelligence / Profile preview

Multiple urogenital tract pathogens

Molecular classification
Pathogen, Microorganism, Bacteria, Virus, Protozoa
01

Overview

Multiple urogenital tract pathogens refers to a diverse group of microorganisms, including bacteria, viruses, fungi, and protozoa, that infect the urinary and reproductive systems (StatPearls, 2023). Common bacterial agents include Escherichia coli, the primary cause of urinary tract infections (UTIs), as well as Chlamydia trachomatis and Neisseria gonorrhoeae, which are major causes of sexually transmitted infections (STIs) (CDC, 2021). These pathogens utilize various virulence factors to adhere to mucosal surfaces, evade the host immune response, and cause tissue damage (Nature Reviews Microbiology, 2015). Treatment typically involves antimicrobial agents tailored to the specific pathogen, such as antibiotics for bacterial infections or antivirals for viral ones (NCBI, 2022). However, the rise of multi-drug resistant strains poses a significant challenge to clinical management and drug development (WHO, 2023). Because this term encompasses a wide variety of distinct biological entities rather than a single molecular target, it is generally classified as a disease category or indication in therapeutic contexts.

Other names
Urogenital pathogensGenitourinary pathogensUTI pathogensSTI pathogensUropathogens
02

Mechanism of action

Inhibition of bacterial cell wall synthesis, inhibition of protein synthesis via ribosomal binding, and inhibition of DNA replication through DNA gyrase interference (NCBI, 2022).

03

Biological functions

Microbial pathogenesisAdhesionBiofilm formationImmune evasion
04

Disease associations

Urinary tract infectionSexually transmitted infectionCystitisPyelonephritisUrethritis
05

Safety considerations

Antimicrobial resistanceDysbiosis of the vaginal or gut microbiomeClostridioides difficile-associated diarrheaDrug-induced hypersensitivity
06

Interacting drugs

Ciprofloxacin

5 more in the full profile.

07

Biomarkers

Urine cultureNucleic acid amplification test (NAAT)Leukocyte esteraseNitrite testC-reactive protein

Beyond the preview

Go deeper on Multiple urogenital tract pathogens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple urogenital tract pathogens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call